Predicted to enable estradiol 17-beta-dehydrogenase activity and testosterone dehydrogenase (NAD+) activity. Acts upstream of or within in utero embryonic development and placenta development. Predicted to be located in intracellular membrane-bounded organelle. Is expressed in several structures, including adrenal gland; genitourinary system; gut; liver; and retina. Orthologous to human HSD17B2 (hydroxysteroid 17-beta dehydrogenase 2). [provided by Alliance of Genome Resources, Apr 2022]